Pettinga Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Buy
1,063
+2
+0.2% +$466 0.04% 128
2026
Q1
$259K Sell
1,061
-23
-2% -$5.36K 0.05% 129
2025
Q4
$224K Buy
+1,084
New +$214K 0.04% 135
2020
Q1
Sell
-1,424
Closed -$208K 88
2019
Q4
$208K Sell
1,424
-500
-26% -$67.8K 0.11% 81
2019
Q3
$249K Buy
1,924
+100
+5% +$13.2K 0.13% 79
2019
Q2
$254K Sell
1,824
-391
-18% -$54.1K 0.13% 80
2019
Q1
$310K Buy
2,215
+3
+0.1% +$402 0.17% 68
2018
Q4
$286K Buy
+2,212
New +$309K 0.19% 70

Other funds holding JNJ

Pettinga Financial Advisors's JNJ Position: Q2 2026 in Review

Pettinga Financial Advisors increased its Johnson & Johnson (JNJ) stake by 0.19% in Q2 2026, buying an estimated $466 and bringing the position to 1,063 shares worth $270K. The position accounts for 0.04% of the portfolio, ranked #128.

Pettinga Financial Advisors first reported a position in JNJ in Q4 2018 and has held it in 8 quarters since. The position peaked at $310K in Q1 2019. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Pettinga Financial Advisors held 1,063 shares of Johnson & Johnson worth $270K as of Q2 2026.
  • Pettinga Financial Advisors bought 2 Johnson & Johnson shares in Q2 2026, an estimated $466.
  • Johnson & Johnson made up 0.04% of Pettinga Financial Advisors's portfolio in Q2 2026, its #128 holding.
  • Pettinga Financial Advisors first reported a position in Johnson & Johnson in Q4 2018 and has held it in 8 quarters since.
  • Pettinga Financial Advisors's Johnson & Johnson position peaked at $310K in Q1 2019.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Pettinga Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.